Split History
ETFs Holding ABUS »    ABUS Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arbutus Biopharma is a clinical-stage biopharmaceutical company utilizing its virology expertise to develop therapeutics that target specific viral diseases. Co.'s focus areas include Hepatitis B virus (HBV), SARS-CoV-2 and other coronaviruses. Co.'s product pipeline consists of the following programs: GalNAc RNAi, which is a subcutaneously-delivered RNA interference therapeutic targeted to hepatocytes; Oral Capsid Inhibitor, which is a capsid inhibitor; Oral PD-L1 Inhibitor, which is an oral PD-L1 inhibitor that has the potential to reawaken patients' HBV-specific immune response; and Oral HBV RNA Destabilizer, which is is Co.'s oral HBV specific RNA destabilizer. According to our ABUS split history records, Arbutus Biopharma has had 1 split.
ABUS split history picture
Arbutus Biopharma (ABUS) has 1 split in our ABUS split history database. The split for ABUS took place on November 04, 2010. This was a 1 for 5 reverse split, meaning for each 5 shares of ABUS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.

When a company such as Arbutus Biopharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ABUS split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Arbutus Biopharma shares, starting with a $10,000 purchase of ABUS, presented on a split-history-adjusted basis factoring in the complete ABUS split history. ABUS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 03/27/2024
Start price/share: $21.49
End price/share: $2.60
Dividends collected/share: $0.00
Total return: -87.90%
Average Annual Total Return: -19.04%
Starting investment: $10,000.00
Ending investment: $1,210.48
Years: 10.00
Date Ratio
11/04/20101 for 5
Pluri Inc. (PLUR)
Rent the Runway, Inc. (RENT)
Castor Maritime Inc. (CTRM)
ETAO International Co., Ltd. (ETAO)
Aterian, Inc. (ATER)
Chipotle Mexican Grill, Inc. (CMG)
Moleculin Biotech, Inc. (MBRX)
Longeveron Inc. (LGVN)
Intrusion Inc. (INTZ)
MicroSectorsTM Travel -3X Inverse Leveraged ETNs due May 29, 2042 (FLYD)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ABUS Insider Buying

ABUS Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.